Dynamic Capital Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$201K Buy
+1,880
New +$193K 1.68% 29
2018
Q3
Sell
-6,105
Closed -$671K 136
2018
Q2
$671K Buy
+6,105
New +$636K 1.07% 28
2018
Q1
Sell
-16,135
Closed -$1.59M 126
2017
Q4
$1.59M Buy
+16,135
New +$1.53M 0.55% 49
2017
Q3
Sell
-27,183
Closed -$3.02M 269
2017
Q2
$3.02M Buy
+27,183
New +$2.87M 0.68% 36
2016
Q2
Sell
-7,351
Closed -$525K 422
2016
Q1
$525K Buy
7,351
+3,651
+99% +$245K 0.2% 171
2015
Q4
$263K Sell
3,700
-7,218
-66% -$485K 0.13% 279
2015
Q3
$671K Sell
10,918
-54,942
-83% -$3.84M 0.18% 206
2015
Q2
$4.78M Buy
+65,860
New +$4.86M 1.21% 20
2014
Q1
Sell
-39,868
Closed -$2.13M 419
2013
Q4
$2.13M Buy
+39,868
New +$2.36M 0.4% 66
2013
Q3
Sell
-3,600
Closed -$218K 433
2013
Q2
$218K Buy
+3,600
New +$214K 0.06% 321

Other funds holding DGX

Dynamic Capital Management's DGX Position: Q3 2019 in Review

Dynamic Capital Management opened a new position in Quest Diagnostics (DGX) in Q3 2019: 1,880 shares worth $201K. The stake represents 1.68% of the portfolio and ranks #29 among its holdings. This is a return to the name: Dynamic Capital Management previously reported a position in DGX as recently as Q2 2018.

Dynamic Capital Management first reported a position in DGX in Q2 2013 and has held it in 10 quarters since. The position peaked at $4.78M in Q2 2015. 676 funds tracked by Wall St. Rank hold DGX as of Q3 2019.

  • Dynamic Capital Management held 1,880 shares of Quest Diagnostics worth $201K as of Q3 2019.
  • Quest Diagnostics was a new Dynamic Capital Management position in Q3 2019.
  • Quest Diagnostics made up 1.68% of Dynamic Capital Management's portfolio in Q3 2019, its #29 holding.
  • Dynamic Capital Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 10 quarters since.
  • Dynamic Capital Management's Quest Diagnostics position peaked at $4.78M in Q2 2015.
  • 676 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2019.

Based on Dynamic Capital Management's 13F filing for Q3 2019, filed 28 Oct 2019.